COVID-19 Vaccine Stock in Boalemo Regency Estimated to Last 16 Days

Agus Dwi Darmawan 19/10/2021 17:02 WIB

Bagikan URL has been copied

Memuat...

As for vaccination coverage at the provincial level, the total first dose vaccinations in Gorontalo have reached 46.5 percent, or 436,380 vaccine recipients.

Estimated Remaining Vaccine Days Based on Stock in Selected Districts of Gorontalo

A Font Kecil
A Font Sedang
A Font Besar

Access single data

COVID-19 Vaccine Stock in Boalemo Regency Estimated to Last 16 Days

Want to get more access to Data Stories with a more affordable price? Subscribe.

By subscribing, you join us in presenting quality data.

Get:

Premium Data Stories access
Comfortable reading without ads
Download data in XLS, PDF, and image format
Access to data source information

Basic

~~Rp100.000~~

Rp50.000/month

Professional

~~Rp100.000~~

Rp150.000/month

Institutional For organizations

We accept the following payments:

Some payment methods are still in the process of being activated.

Estimated Remaining Vaccine Days Based on Stock in Selected Districts of Gorontalo

Download

Source

A Small
A Medium
A Bigger

Boalemo Regency in Gorontalo reported the use of 86,408 vaccine doses as of Monday, October 18, 2021. According to the Ministry of Health, the available vaccine stock in this region will run out in 16 days. This remaining usage period is calculated based on the available stock of 10,574 doses and an average daily usage of 649 doses over the last week.

Boalemo recorded the highest vaccination growth this week compared to other regions in Gorontalo. Weekly vaccination figures grew by seven percent compared to last week's total of 80,284 doses.

Meanwhile, the first dose vaccination coverage in Boalemo Regency has only reached 48.83 percent. This figure is below the average for regencies/cities in Gorontalo.

At the provincial level, the total first dose vaccination in Gorontalo has reached 46.5 percent, covering 436,380 vaccine recipients. The second dose vaccination has reached 22.34 percent, covering 209,640 vaccine recipients.

"Disclosure: This is an AI-generated translation of the original article. We strive for accuracy, but please note that automated translations may contain errors or slight inconsistencies."